Holland K D, Naritoku D K, McKeon A C, Ferrendelli J A, Covey D F
Department of Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110.
Mol Pharmacol. 1990 Jan;37(1):98-103.
The convulsant and/or anticonvulsant activity of unsubstituted and mono-alkyl-substituted cyclopentanones and cyclohexanones were examined by testing the ability of these compounds to produce seizures or to inhibit seizures induced by pentylenetetrazol and maximal electroshock in CF-1 mice. In addition, these compounds were tested for their ability to bind to the picrotoxin receptor. The unsubstituted compounds, cyclopentanone and cyclohexanone, prevented both pentylnetetrazol- and maximal electroshock-induced seizures. Cyclopentanones and cyclohexanones with small (less than 3 carbon atoms) alkyl substituents in the 2-position were also anticonvulsant; all of these compounds, except 2-ethylcyclohexanone, blocked both pentylenetrazol- and maximal electroshock-induced seizures. 2-Ethylcyclohexanone was very effective against pentylenetetrazol seizures but did not prevent maximal electroshock seizures. Cyclohexanones with larger alkyl substituents in the 2-position, 2-propylcyclohexanone and 2-t-butylcyclohexanone, caused clonic seizures following injection into mice. Of the cyclopentanones and cyclohexanones with alkyl substitutions in the 3-position that were studied, one was an anticonvulsant (3-methylcyclopentanone), one was a mixed convulsant/anticonvulsant (3-ethylcyclohexanone), and the other two (3-ethylcyclopentanone and 3-t-butylcyclohexanone) were convulsants. Finally, two cyclohexanones with alkyl substituents in the 4-position were studied. Both 4-ethylcyclohexanone and 4-t-butylcyclohexanone produced convulsions when injected into mice. All the neuroactive cyclopentanones and cyclohexanones competitively displaced [35S]t-butylbicyclophosphorothionate, a ligand specific for the picrotoxin receptor, from rat brain membranes. The convulsant compounds were generally more potent than the anticonvulsants. The cyclohexanones were more potent than their corresponding cyclopentanones and the binding potency of both increased as the size of the alkyl substituent increased. These results suggest that cyclopentanone, cyclohexanone, and their alkyl-substituted derivatives act at the picrotoxin receptor to increase or decrease neuronal activity. Thus, they appear to have sites and mechanisms of action similar to those of the neuroactive gamma-butyrolactones and gamma-thiobutyrolactones.
通过测试未取代和单烷基取代的环戊酮及环己酮在CF-1小鼠中引发癫痫或抑制由戊四氮和最大电休克诱导的癫痫的能力,来检测这些化合物的惊厥和/或抗惊厥活性。此外,还测试了这些化合物与印防己毒素受体结合的能力。未取代的化合物环戊酮和环己酮可预防戊四氮和最大电休克诱导的癫痫发作。在2位带有小(少于3个碳原子)烷基取代基的环戊酮和环己酮也具有抗惊厥作用;除2-乙基环己酮外,所有这些化合物都能阻断戊四氮和最大电休克诱导的癫痫发作。2-乙基环己酮对戊四氮诱导的癫痫发作非常有效,但不能预防最大电休克诱导的癫痫发作。在2位带有较大烷基取代基的环己酮,2-丙基环己酮和2-叔丁基环己酮注射到小鼠体内后会引起阵挛性癫痫发作。在所研究的在3位带有烷基取代基的环戊酮和环己酮中,一种是抗惊厥剂(3-甲基环戊酮),一种是混合惊厥/抗惊厥剂(3-乙基环己酮),另外两种(3-乙基环戊酮和3-叔丁基环己酮)是惊厥剂。最后,研究了两种在4位带有烷基取代基的环己酮。4-乙基环己酮和4-叔丁基环己酮注射到小鼠体内时都会引起惊厥。所有具有神经活性的环戊酮和环己酮都能竞争性地将[35S]叔丁基双环磷硫代酸盐(一种印防己毒素受体特异性配体)从大鼠脑膜中置换出来。惊厥性化合物通常比抗惊厥性化合物更有效。环己酮比其相应的环戊酮更有效,并且两者的结合效力都随着烷基取代基尺寸的增加而增加。这些结果表明,环戊酮、环己酮及其烷基取代衍生物作用于印防己毒素受体,以增加或降低神经元活性。因此,它们似乎具有与神经活性γ-丁内酯和γ-硫代丁内酯相似的作用位点和作用机制。